EXELIXIS AND CATALENT ENTER INTO NEW LICENSE AGREEMENT FOR THREE ADC PROGRAMSDeveloped using Catalent’s SMARTag® technology platformLearn More BIOLOGICSCreate better biologic treatments and speed your path to market with our range of advanced technologies and services.Learn More DEVELOPING BIOLOGICS DRUGS IS SCIENCEAccelerating Advanced Treatments & Vaccines is Art.Learn More How can we work together BIOLOGICS GENE THERAPY CELL THERAPY TECHNOLOGIES Latest News Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline UPTEMPO VIRTUOSO™ AAV PLATFORM PROCESS A scalable, CGMP-ready process providing early-stage partners with accelerated timelines for production of their clinical material. LEARN MORE PLASMID DNA Catalent offers plasmid DNA supply and solutions from early-stage lead identification to GMP manufacturing for clinical- and commercial-scale. FORMULATION DEVELOPMENT The formulation scientists at Catalent Biologics have experience in a variety of formulations and product presentations to help you develop and deliver your clinical or commercial formulation, faster. BIOLOGICS ANALYTICAL METHODS: TRENDS AND STRATEGIES TO ACCELERATE BIOLOGICS DEVELOPMENT In this webinar, experts describe how the stepwise approach for bioanalytical testing can be used to reduce risks and challenges present in biologics development. BIOLOGICS NETWORK Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. LEARN MORE JOIN OUR TEAM Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. NEWS Catalent Opens One of the World’s Largest Commercial-Scale Cell Therapy Manufacturing Facilities at its European Center of Excellence for Cell Therapies in Gosselies, Belgium Exelixis and Catalent Enter into New License Agreement for Three Antibody-Drug Conjugate Programs with the Potential to Accelerate Exelixis’ Biologics Pipeline Catalent Expands Biologics Analytical Capabilities with New Laboratories at Center of Excellence in Kansas City, Missouri Xenetic Biosciences, Inc. Engages Catalent for Clinical Manufacturing to Advance DNase-Based Oncology Platform Towards Phase 1 Study VIEW ALL NEWS EVENTS Strategic Considerations for Scaling Up the Manufacturing of Cell Therapies Advanced Therapies Week 2023 CASSS WCBP 2023 2nd Annual mRNA-Based Therapeutics Summit Europe VIEW ALL EVENTS EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parenteral Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays VIEW ALL ARTICLES
